Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
This final rulemaking is issued by the Acting Deputy Administrator of the Drug Enforcement Administration (DEA) to place 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) and N-benzylpiperazine (BZP) into Schedule I of the Controlled Substances Act (CSA). This action by the DEA Acting Deputy Administrator is based on a scheduling recommendation by the Department of Health and Human Services (DHHS) and a DEA review indicating that 2C-T-7 and BZP meet the criteria for placement in Schedule I of the CSA. This final rule will continue to impose the regulatory controls and criminal sanctions of Schedule I substances on the manufacture, distribution, and possession of 2C-T-7 and BZP.
D000662:Amphetamines / Q000009:adverse effects; D004348:Drug Labeling; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D010627:Phenethylamines / Q000009:adverse effects / Q000032:analysis / Q000145:classification*; D010879:Piperazines / Q000009:adverse effects / Q000032:analysis / Q000145:classification*; D011634:Public Health; D019966:Substance-Related Disorders; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration
D000662:Amphetamines; D010627:Phenethylamines; D010879:Piperazines